Jesus Campagna

514 total citations
26 papers, 364 citations indexed

About

Jesus Campagna is a scholar working on Molecular Biology, Physiology and Computational Theory and Mathematics. According to data from OpenAlex, Jesus Campagna has authored 26 papers receiving a total of 364 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 13 papers in Physiology and 6 papers in Computational Theory and Mathematics. Recurrent topics in Jesus Campagna's work include Alzheimer's disease research and treatments (10 papers), Computational Drug Discovery Methods (6 papers) and Extracellular vesicles in disease (5 papers). Jesus Campagna is often cited by papers focused on Alzheimer's disease research and treatments (10 papers), Computational Drug Discovery Methods (6 papers) and Extracellular vesicles in disease (5 papers). Jesus Campagna collaborates with scholars based in United States, Japan and France. Jesus Campagna's co-authors include Varghese John, Patricia Spilman, Dale E. Bredesen, Tina Bilousova, Karen S. Poksay, Clare Peters‐Libeu, Karen H. Gylys, Chunni Zhu, Olivia Gorostiza and Mikhail Melnik and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Jesus Campagna

24 papers receiving 364 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jesus Campagna United States 11 185 146 66 60 54 26 364
Ang Xing China 7 118 0.6× 132 0.9× 52 0.8× 57 0.9× 50 0.9× 10 321
Nipun Chopra United States 8 199 1.1× 221 1.5× 65 1.0× 59 1.0× 51 0.9× 14 467
Edgar Dawkins Australia 9 174 0.9× 214 1.5× 71 1.1× 44 0.7× 81 1.5× 10 428
Tapan K. Khan United States 9 156 0.8× 201 1.4× 98 1.5× 66 1.1× 44 0.8× 12 429
Joana S. Cristóvão Portugal 12 314 1.7× 250 1.7× 48 0.7× 69 1.1× 46 0.9× 20 549
Deborah Pietrobono Italy 15 185 1.0× 137 0.9× 30 0.5× 49 0.8× 48 0.9× 28 479
Laura Buizza Italy 9 197 1.1× 147 1.0× 40 0.6× 43 0.7× 43 0.8× 10 404
Seung Hyun Baek South Korea 7 249 1.3× 164 1.1× 40 0.6× 70 1.2× 51 0.9× 8 412
Arames Crameri Switzerland 6 219 1.2× 216 1.5× 45 0.7× 36 0.6× 78 1.4× 6 428
Gayathri Ramaswamy United States 8 266 1.4× 295 2.0× 52 0.8× 160 2.7× 81 1.5× 14 549

Countries citing papers authored by Jesus Campagna

Since Specialization
Citations

This map shows the geographic impact of Jesus Campagna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jesus Campagna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jesus Campagna more than expected).

Fields of papers citing papers by Jesus Campagna

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jesus Campagna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jesus Campagna. The network helps show where Jesus Campagna may publish in the future.

Co-authorship network of co-authors of Jesus Campagna

This figure shows the co-authorship network connecting the top 25 collaborators of Jesus Campagna. A scholar is included among the top collaborators of Jesus Campagna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jesus Campagna. Jesus Campagna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cohn, Whitaker, Jesus Campagna, Jessica Lee, et al.. (2025). Discovery of a small molecule secreted clusterin enhancer that improves memory in Alzheimer’s disease mice. PubMed. 2(1). 7–7.
2.
Campagna, Jesus, Chunni Zhu, Jessica Lee, et al.. (2025). Discovery of an APP-selective BACE1 inhibitor for Alzheimer's disease. Neurotherapeutics. 22(5). e00610–e00610.
3.
Okabe, N., Xiaofei Wei, Jesus Campagna, et al.. (2025). Parvalbumin interneurons regulate rehabilitation-induced functional recovery after stroke and identify a rehabilitation drug. Nature Communications. 16(1). 2556–2556. 3 indexed citations
4.
Wei, Xiaofei, Jesus Campagna, Whitaker Cohn, et al.. (2024). A therapeutic small molecule enhances γ-oscillations and improves cognition/memory in Alzheimer’s disease model mice. Proceedings of the National Academy of Sciences. 121(33). e2400420121–e2400420121. 3 indexed citations
5.
Okawa, Hiroko, Takeru Kondo, Akishige Hokugo, et al.. (2022). Fluorescent risedronate analogue 800CW-pRIS improves tooth extraction-associated abnormal wound healing in zoledronate-treated mice. SHILAP Revista de lepidopterología. 2(1). 112–112. 3 indexed citations
6.
Campagna, Jesus, et al.. (2022). Identification of a Papain-Like Protease Inhibitor with Potential for Repurposing in Combination with an Mpro Protease Inhibitor for Treatment of SARS-CoV-2. Archives of Clinical and Biomedical Research. 6(6). 1 indexed citations
7.
Zhu, Chunni, Tina Bilousova, Mikhail Melnik, et al.. (2021). Correction to: Pharmacological inhibition of nSMase2 reduces brain exosome release and α-synuclein pathology in a Parkinson’s disease model. Molecular Brain. 14(1). 108–108. 4 indexed citations
8.
Miyoshi, Emily, Tina Bilousova, Mikhail Melnik, et al.. (2021). Exosomal tau with seeding activity is released from Alzheimer's disease synapses, and seeding potential is associated with amyloid beta. Laboratory Investigation. 101(12). 1605–1617. 42 indexed citations
9.
Zhu, Chunni, Tina Bilousova, Mikhail Melnik, et al.. (2021). Pharmacological inhibition of nSMase2 reduces brain exosome release and α-synuclein pathology in a Parkinson’s disease model. Molecular Brain. 14(1). 70–70. 20 indexed citations
10.
Liu, Jian, Jesus Campagna, Varghese John, et al.. (2020). A Small-Molecule Approach to Restore a Slow-Oxidative Phenotype and Defective CaMKIIβ Signaling in Limb Girdle Muscular Dystrophy. Cell Reports Medicine. 1(7). 100122–100122. 5 indexed citations
11.
Shu, Cynthia, Ekaterina Mokhonova, Robert Damoiseaux, et al.. (2020). High-throughput screening identifies modulators of sarcospan that stabilize muscle cells and exhibit activity in the mouse model of Duchenne muscular dystrophy. Skeletal Muscle. 10(1). 26–26. 3 indexed citations
12.
Campagna, Jesus, Patricia Spilman, Dongsheng Bai, et al.. (2018). A small molecule ApoE4-targeted therapeutic candidate that normalizes sirtuin 1 levels and improves cognition in an Alzheimer’s disease mouse model. Scientific Reports. 8(1). 17574–17574. 30 indexed citations
13.
Simmons, Bryan J., et al.. (2018). Synthesis of fused indolines by interrupted Fischer indolization in a microfluidic reactor. Tetrahedron Letters. 60(3). 322–326. 2 indexed citations
14.
Bilousova, Tina, Emily Miyoshi, Chunni Zhu, et al.. (2018). Suppression of tau propagation using an inhibitor that targets the DK-switch of nSMase2. Biochemical and Biophysical Research Communications. 499(4). 751–757. 29 indexed citations
15.
Campagna, Jesus, et al.. (2018). Evaluation of an Allosteric BACE Inhibitor Peptide to Identify Mimetics that Can Interact with the Loop F Region of the Enzyme and Prevent APP Cleavage. Journal of Molecular Biology. 430(11). 1566–1576. 8 indexed citations
16.
Poksay, Karen S., Douglas J. Sheffler, Patricia Spilman, et al.. (2017). Screening for Small Molecule Inhibitors of Statin-Induced APP C-terminal Toxic Fragment Production. Frontiers in Pharmacology. 8. 46–46. 3 indexed citations
17.
Campagna, Jesus, et al.. (2016). C O bond formation in a microfluidic reactor: high yield S N Ar substitution of heteroaryl chlorides. Tetrahedron Letters. 57(19). 2059–2062. 14 indexed citations
18.
Spilman, Patricia, Véronique Corset, Olivia Gorostiza, et al.. (2016). Netrin-1 Interrupts Amyloid-β Amplification, Increases sAβPPα in vitro and in vivo, and Improves Cognition in a Mouse Model of Alzheimer’s Disease. Journal of Alzheimer s Disease. 52(1). 223–242. 27 indexed citations
19.
Spilman, Patricia, Olivier Descamps, Olivia Gorostiza, et al.. (2014). The multi-functional drug tropisetron binds APP and normalizes cognition in a murine Alzheimer's model. Brain Research. 1551. 25–44. 34 indexed citations
20.
Descamps, Olivier, Patricia Spilman, Qiang Zhang, et al.. (2013). AβPP-Selective BACE Inhibitors (ASBI): Novel Class of Therapeutic Agents for Alzheimer's Disease. Journal of Alzheimer s Disease. 37(2). 343–355. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026